Cargando…
Pronounced antiseizure activity of the subtype‐selective GABA(A) positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy
AIM: Darigabat is an α2/3/5 subunit‐selective positive allosteric modulator of GABA(A) receptors that has demonstrated broad‐spectrum activity in several preclinical models of epilepsy as well as in a clinical photoepilepsy trial. The objective here was to assess the acute antiseizure effect of dari...
Autores principales: | Gurrell, Rachel, Iredale, Philip, Evrard, Alexis, Duveau, Venceslas, Ruggiero, Céline, Roucard, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532903/ https://www.ncbi.nlm.nih.gov/pubmed/35965432 http://dx.doi.org/10.1111/cns.13927 |
Ejemplares similares
-
Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
por: Janković, Slobodan M, et al.
Publicado: (2021) -
Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease
por: Gronlier, Eloïse, et al.
Publicado: (2023) -
Real‐world antiseizure medication treatment outcomes in drug‐resistant focal epilepsy patients
por: Hatoum, Hind T., et al.
Publicado: (2023) -
Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABA(A)‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers
por: Gurrell, Rachel, et al.
Publicado: (2021) -
Understanding subtype-selective allosteric modulation of GABA(A) receptors
por: Puthenkalam, Roshan, et al.
Publicado: (2012)